• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

婴儿和儿童III级及IV级原发性膀胱输尿管反流的药物治疗与手术治疗随机临床试验结果(美国)。儿童国际反流研究。

Results of a randomized clinical trial of medical versus surgical management of infants and children with grades III and IV primary vesicoureteral reflux (United States). The International Reflux Study in Children.

作者信息

Weiss R, Duckett J, Spitzer A

机构信息

Department of Pediatrics, New York Medical College, Valhalla 10595.

出版信息

J Urol. 1992 Nov;148(5 Pt 2):1667-73. doi: 10.1016/s0022-5347(17)36998-7.

DOI:10.1016/s0022-5347(17)36998-7
PMID:1433585
Abstract

A total of 132 infants and children with grades III and IV primary vesicoureteral reflux was entered into a prospective trial comparing medical to surgical management. Inclusion criteria were an age not exceeding 10 years and a glomerular filtration rate of at least 70 ml. per minute per 1.73 m.2. Children with significant urinary tract malformations and clinical signs/symptoms of dysfunctional voiding were not accepted into the trial. Medical therapy consisted of continuous low dose antibiotic prophylaxis until vesicoureteral reflux resolved. The type of surgical procedure used for the correction of reflux was left to the discretion of the surgeon. Outcome variables included the appearance or progression of renal lesions, rate of renal growth, recurrence rate of urinary tract infection or pyelonephritis, changes in total kidney glomerular filtration rate, development of hypertension and resolution rate of vesicoureteral reflux. Followup at 6, 18, 36 and 54 months after entry included, in addition to history and physical examination, voiding cystourethrography, excretory urography and a urine culture. Of the patients 68 were allocated to the medical group and 64 to the surgical group. They were stratified for age, sex and preexisting renal scarring. Of the patients 10% were boys, 47% were between 2 and 6 years old at entry, 93% had a history of pyelonephritis, 67% had either scarring or thinning of the parenchyma at entry, 87% had grade IV vesicoureteral reflux in at least 1 unit and 56% had bilateral reflux. There were no significant differences in the frequency distribution of entry characteristics between the patients allocated to either group. New renal scarring developed in 22% of medical and 31% of surgical patients (p < 0.4). Growth of kidneys with grade IV vesicoureteral reflux was slightly less than normal in the medical (-0.67 +/- 0.15 standard deviation) and surgical (-0.42 +/- 0.11 standard deviation) groups (p < 0.7). Pyelonephritis occurred in 15 medical patients versus 5 surgical patients (p < 0.05). There was no significant change in glomerular filtration rate within each treatment group and no difference in glomerular filtration rate between groups. No patient had hypertension during the followup period. The disappearance rate of vesicoureteral reflux in patients with grade IV reflux was approximately 8% per year. Of the medical patients 75% still had vesicoureteral reflux after 3 years of observation.(ABSTRACT TRUNCATED AT 400 WORDS)

摘要

132例患有III级和IV级原发性膀胱输尿管反流的婴幼儿和儿童进入了一项前瞻性试验,比较药物治疗和手术治疗。纳入标准为年龄不超过10岁,肾小球滤过率至少为每分钟70 ml/1.73 m²。有明显尿路畸形以及排尿功能障碍临床体征/症状的儿童未纳入该试验。药物治疗包括持续低剂量抗生素预防,直至膀胱输尿管反流消失。用于纠正反流的手术方式由外科医生自行决定。结局变量包括肾脏病变的出现或进展、肾脏生长速率、尿路感染或肾盂肾炎的复发率、总肾肾小球滤过率的变化、高血压的发生以及膀胱输尿管反流的消失率。入组后6、18、36和54个月的随访,除病史和体格检查外,还包括排尿性膀胱尿道造影、排泄性尿路造影和尿培养。68例患者被分配到药物治疗组,64例被分配到手术治疗组。他们按年龄、性别和既往肾瘢痕形成情况进行分层。患者中10%为男孩,47%入组时年龄在2至6岁之间,93%有肾盂肾炎病史,67%入组时存在肾实质瘢痕形成或变薄,87%至少1个单位存在IV级膀胱输尿管反流,56%为双侧反流。分配到两组的患者在入组特征的频率分布上没有显著差异。22%的药物治疗患者和31%的手术治疗患者出现了新的肾瘢痕形成(p<0.4)。IV级膀胱输尿管反流患者的肾脏生长在药物治疗组(-0.67±0.15标准差)和手术治疗组(-0.42±0.11标准差)略低于正常水平(p<0.7)。15例药物治疗患者和5例手术治疗患者发生了肾盂肾炎(p<0.05)。每个治疗组内肾小球滤过率没有显著变化,两组之间肾小球滤过率也没有差异。随访期间没有患者出现高血压。IV级反流患者中膀胱输尿管反流的消失率约为每年8%。75%的药物治疗患者在观察3年后仍有膀胱输尿管反流。(摘要截短至400字)

相似文献

1
Results of a randomized clinical trial of medical versus surgical management of infants and children with grades III and IV primary vesicoureteral reflux (United States). The International Reflux Study in Children.婴儿和儿童III级及IV级原发性膀胱输尿管反流的药物治疗与手术治疗随机临床试验结果(美国)。儿童国际反流研究。
J Urol. 1992 Nov;148(5 Pt 2):1667-73. doi: 10.1016/s0022-5347(17)36998-7.
2
Characteristics at entry of children with severe primary vesicoureteral reflux recruited for a multicenter, international therapeutic trial comparing medical and surgical management. The International Reflux Study in Children.为一项比较药物治疗和手术治疗的多中心国际治疗试验招募的重度原发性膀胱输尿管反流患儿的入组特征。国际儿童反流研究。
J Urol. 1992 Nov;148(5 Pt 2):1644-9. doi: 10.1016/s0022-5347(17)36993-8.
3
Medical management of mild and moderate vesicoureteral reflux: followup studies of infants and young children. A preliminary report of the Southwest Pediatric Nephrology Study Group.轻度和中度膀胱输尿管反流的医学管理:婴幼儿随访研究。西南儿科肾脏病研究组初步报告。
J Urol. 1992 Nov;148(5 Pt 2):1683-7. doi: 10.1016/s0022-5347(17)37002-7.
4
Cessation of vesicoureteral reflux for 5 years in infants and children allocated to medical treatment. The International Reflux Study in Children.接受药物治疗的婴幼儿和儿童膀胱输尿管反流停止5年。国际儿童反流研究。
J Urol. 1992 Nov;148(5 Pt 2):1662-6. doi: 10.1016/s0022-5347(17)36997-5.
5
Renal scars and parenchymal thinning in children with vesicoureteral reflux: a 5-year report of the International Reflux Study in Children (European branch).膀胱输尿管反流患儿的肾瘢痕和实质变薄:儿童国际反流研究(欧洲分支)的5年报告
J Urol. 1992 Nov;148(5 Pt 2):1653-6. doi: 10.1016/s0022-5347(17)36995-1.
6
Followup of conservatively treated children with high and low grade vesicoureteral reflux: a prospective study.保守治疗的儿童高低度膀胱输尿管反流的随访:一项前瞻性研究。
J Urol. 1992 Nov;148(5 Pt 2):1688-92. doi: 10.1016/s0022-5347(17)37003-9.
7
A nonsurgical approach to the management of primary vesicoureteral reflux.原发性膀胱输尿管反流管理的非手术方法。
J Urol. 1987 Oct;138(4 Pt 2):941-6. doi: 10.1016/s0022-5347(17)43465-3.
8
The Swedish infant high-grade reflux trial: Study presentation and vesicoureteral reflux outcome.瑞典婴幼儿重度反流试验:研究报告及膀胱输尿管反流结果
J Pediatr Urol. 2017 Apr;13(2):130-138. doi: 10.1016/j.jpurol.2016.08.026. Epub 2016 Oct 24.
9
New renal scars in children with urinary tract infections, vesicoureteral reflux and voiding dysfunction: a prospective evaluation.患有尿路感染、膀胱输尿管反流和排尿功能障碍的儿童的新肾瘢痕:一项前瞻性评估。
J Urol. 1997 Aug;158(2):566-8.
10
The Swedish infant high-grade reflux trial: UTI and renal damage.瑞典婴幼儿重度反流试验:尿路感染与肾损伤
J Pediatr Urol. 2017 Apr;13(2):146-154. doi: 10.1016/j.jpurol.2016.12.023. Epub 2017 Feb 2.

引用本文的文献

1
Effectiveness of various treatment modalities in children with vesicoureteral reflux grades II-IV: a systematic review and network meta-analysis.各种治疗方式在 II-IV 级膀胱输尿管反流患儿中的疗效:系统评价和网络荟萃分析。
BMJ Paediatr Open. 2023 Nov;7(1). doi: 10.1136/bmjpo-2023-002096.
2
Long term outcomes of Cohen's cross trigonal reimplantation for primary vesicoureteral reflux in poorly functioning kidney.科恩氏交叉三角区再植术治疗肾功能不良的原发性膀胱输尿管反流的长期疗效
World J Clin Cases. 2023 Jun 6;11(16):3750-3755. doi: 10.12998/wjcc.v11.i16.3750.
3
Do Various Treatment Modalities of Vesicoureteral Reflux Have Any Adverse Effects in Pediatric Patients? A Meta-Analysis.
各种治疗方法对小儿膀胱输尿管反流是否有不良影响?一项荟萃分析。
Urol Int. 2021;105(11-12):1002-1010. doi: 10.1159/000518603. Epub 2021 Sep 23.
4
Guidelines for the medical management of pediatric vesicoureteral reflux.小儿膀胱输尿管反流的医学管理指南。
Int J Urol. 2020 Jun;27(6):480-490. doi: 10.1111/iju.14223. Epub 2020 Apr 1.
5
Brazilian consensus on vesicoureteral reflux-recommendations for clinical practice.巴西尿路上皮反流共识——临床实践建议。
Int Braz J Urol. 2020 Jul-Aug;46(4):523-537. doi: 10.1590/S1677-5538.IBJU.2019.0401.
6
Interventions for primary vesicoureteric reflux.原发性膀胱输尿管反流的干预措施。
Cochrane Database Syst Rev. 2019 Feb 20;2(2):CD001532. doi: 10.1002/14651858.CD001532.pub5.
7
Predictors of grade 3-5 vesicoureteral reflux in infants ≤ 2 months of age with pyelonephritis.≤2 个月龄肾盂肾炎婴儿发生 3-5 级膀胱输尿管反流的预测因素。
Pediatr Nephrol. 2019 May;34(5):907-915. doi: 10.1007/s00467-018-4167-0. Epub 2018 Dec 26.
8
Predicting long-term renal damage in children with vesicoureteral reflux under conservative initial management: 205 cases in a tertiary referral center.预测保守初始治疗下小儿膀胱输尿管反流的长期肾脏损害:一家三级转诊中心的205例病例
Cent European J Urol. 2018;71(1):142-147. doi: 10.5173/ceju.2018.1513. Epub 2017 Jan 29.
9
Feasibility of superb microvascular imaging to detect high-grade vesicoureteral reflux in children with urinary tract infection.超声造影微血管成像技术在诊断儿童尿路感染性高分级膀胱输尿管反流中的可行性。
Eur Radiol. 2018 Jan;28(1):66-73. doi: 10.1007/s00330-017-4974-x. Epub 2017 Jul 28.
10
Controversies Regarding Management of Vesico-ureteric Reflux.关于膀胱输尿管反流治疗的争议。
Indian J Pediatr. 2017 Jul;84(7):540-544. doi: 10.1007/s12098-017-2359-4. Epub 2017 May 6.